Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts From Swiss Vaults to Digital Wallets: How MKS PAMP is Modernizing the Gold Standard February 5, 2026 Uranium Bull Market Isn’t Over, but Volatility Lies Ahead February 5, 2026 Precious Metals Price Update: Gold, Silver, PGMs Stage Recovery After Crash February 5, 2026